Dental Pain Clinical Trial
Official title:
A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Indomethacin Test Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars
Verified date | March 2012 |
Source | Iroko Pharmaceuticals, LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
The purpose of this study is to determine whether Indomethacin Test Formulation Capsules are safe and effective for the treatment of dental pain.
Status | Completed |
Enrollment | 203 |
Est. completion date | December 2009 |
Est. primary completion date | December 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Patient is male or female between 18 and 50 years of age - For women of child-bearing potential: a woman who is not pregnant and not nursing, and who is practicing an acceptable method of birth control - Patient requires extraction of 2 or more third molars - Patient must be willing to stay at the study site for at least 8 hours after dosing of the study drug Exclusion Criteria: - Patient has hypersensitivity, allergy, or clinically significant intolerance to any medications to be used in the study, or related drugs - Patient has a current disease or history of a disease that will impact the study or the patient's well-being - Patient has used or intends to use any of the medications that are prohibited by the protocol - Patient has a history of drug or alcohol abuse or dependence, or patient has a positive urine drug screen or alcohol breathalyzer test - Patient has taken another investigational drug within 30 days prior to Screening |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Premier Research Group Limited | Austin | Texas |
Lead Sponsor | Collaborator |
---|---|
Iroko Pharmaceuticals, LLC |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Total Patient Pain Relief Over 0 to 8 Hours. | Total patient pain relief was assessed as a time-weighted sum of the patient pain assessments at each individual time point from 0-8 hours. Values for TOTPAR are measured from 0 to 4 on the Pain Relief Scale 0 None Min; 1 A little; 2 Some; 3 A lot; 4 Complete Max The TOTPAR is a weighted measure of the observations; the minimum possible value is 0 and the maximum possible value is 32. |
8 hours | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00985439 -
Study of Diclofenac Capsules to Treat Dental Pain
|
Phase 2 | |
Completed |
NCT00943098 -
Evaluation of the Efficacy and Safety of Diclofenac HPBCD 75mg/ml in Treatment of Pain Following Dental Surgery
|
Phase 3 | |
Completed |
NCT00954356 -
Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction
|
Phase 2 | |
Completed |
NCT00942448 -
Evaluation of the Efficacy and Safety of Diclofenac HPBCD 25, 50 mg/ml in the Treatment of Post-surgical Pain Following Dental Surgery
|
Phase 3 | |
Completed |
NCT02966067 -
A Split Mouth Trial to Compare Microneedles vs. Standard Needles in Dental Anaesthetic Delivery
|
N/A | |
Completed |
NCT01960114 -
Study of Long-Acting Acetaminophen in Postoperative Dental Pain
|
Phase 2 | |
Completed |
NCT01229228 -
Study of Naproxen Capsules to Treat Dental Pain
|
Phase 2 | |
Completed |
NCT01177423 -
Efficiency Evaluation of Intradiploic Intra-osseus Anesthesia Versus Inferior Alveolar Nerve Block
|
N/A | |
Completed |
NCT03328208 -
Nonpharmacologic Reduction of Periprocedural Distress and Drug Use
|
N/A | |
Completed |
NCT05236101 -
Validation of Child Drawing Hospital Scale (CD: H) and the Place of the Drawing in the Evaluation of Dental Anxiety
|
N/A | |
Completed |
NCT00542035 -
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
|
Phase 2 | |
Completed |
NCT04231955 -
Comparison of Different Pain Rating Scales in Patients With Symptomatic Teeth
|
N/A | |
Completed |
NCT02096926 -
Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery
|
Phase 4 | |
Completed |
NCT05369936 -
Pain Perception: on Relationships Between Dental Anxiety and Olfaction
|
N/A | |
Recruiting |
NCT05351099 -
Dental Block for Pain Relief in ED Dental Pain Patients
|
||
Not yet recruiting |
NCT06269406 -
A Combination of Ibuprofen With Curcumin Covered With Liquorice Root Supplementation in the Management of Postoperative Dental Pain in Adults
|
N/A | |
Recruiting |
NCT05443009 -
Self-Reported Pain in Children Submitted to Single Infiltration of Articaine During Primary Molar Extraction
|
Phase 4 | |
Terminated |
NCT02161354 -
Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars
|
Phase 2 | |
Completed |
NCT04949126 -
Self Medication in Odontology (AUDE)
|
||
Completed |
NCT03652818 -
Dental Pain Study of Analgesics in Patients Undergoing Molar Removal
|
Phase 2 |